Clinical Trial

Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome

Study acronym: EBSMTMS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Bariatric surgery (BS) is known to improve the components of metabolic syndrome (MS) in obese patients. However, few studies have evaluated the impact of bariatric surgery versus medical therapy (MT) in patients with MS, especially in patients with low body mass index (BMI). This study aimed to assess the effect of bariatric surgery on MS in patients with low BMI by comparing BS (BMI\<35 kg/m2 and BMI≥35 kg/m2) with MT (BMI\<35 kg/m2). A retrospective study including patients with MS undergoing bariatric surgery and medical therapy at a single institution. We follow up the 5 years effect of bariatric surgery versus medical therapy on the remission of MS, its individual components, atherosclerotic cardiovascular disease (ASCVD) risk, and medication used.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-05-02; most recent amendment 2024-08-16.
Trial Details
NCT Number NCT05363059
Lead Sponsor Third Military Medical University
Conditions Metabolic Syndrome
Enrollment 200 participants
Start Date 2010-05-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-20